津巴布韦的儿童癌症:对KidzCan数据库的审查
Laura P V Sibanda1,2, Anel Van Zyl1, Tonya M Esterhuizen1,3
1Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
JCO global oncology
|June 11, 2025
概括
津巴布韦2015-2021年儿童癌症发病率显示比以前的数据更高. 关键的癌症包括质母细胞瘤,白血病和视网母细胞瘤,为世界卫生组织2030年目标制定政策提供信息.
科学领域:
- 儿科瘤学 儿科瘤学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 在低收入和中等收入国家,儿童癌症发病率数据很少.
- 准确的发病率对于有效的癌症控制策略和政策规划至关重要.
- 津巴布韦的癌症注册数据为了解国家儿童癌症负担提供了基础.
研究的目的:
- 估计2015年1月至2021年12月期间津巴布韦儿童癌症的发生率.
- 为该地区儿童恶性瘤提供最新的流行病学数据.
- 为国家癌症控制政策提供信息,为全球儿童癌症倡议做出贡献.
主要方法:
- 数据从KidzCan津巴布韦数据库和患者档案中提取.
- 收集了人口统计信息,癌症诊断和孤儿身份.
- 根据年龄特定的发病率是根据联合国人口估计的0-14岁和0-19岁儿童的发病率计算的.
主要成果:
- 确定了1090例儿童癌症病例;分析了1024例.
- 诊断时的中位数年龄为4岁,54.2%的患者年龄为0-4岁.
- 常见的癌症包括神经母细胞瘤 (22.1%),急性白血病 (21%) 和视网膜母细胞瘤 (15%). 发病率超过了之前的报道.
结论:
- 该研究为津巴布韦提供了重要的儿童癌症发病率数据.
- 这些发现可以帮助制定政策,以实现世界卫生组织2030年儿童癌症治愈率的目标.
- 强调像KidzCan这样的组织在支持国家儿童癌症管理工作中的重要作用.
相关概念视频
01:21Cancer Survival Analysis
331
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K